|
US2014248357A1
|
|
Respiratory disease treatment
|
|
WO2011110858A1
|
|
Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
|
|
WO2011098801A1
|
|
Inflammatory disease treatment
|
|
WO2011098799A2
|
|
Respiratory disease treatment
|
|
WO2010150014A1
|
|
5r- 5 -deuterated glitazones for respiratory disease treatment
|
|
GB201002235D0
|
|
Respiratory disease treatment.
|
|
WO2011098746A1
|
|
Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
|
|
GB201001893D0
|
|
Respiratory disease treatment
|
|
MX2011007036A
|
|
Sulfonamide compounds for the treatment of respiratory disorders.
|
|
EA019339B1
|
|
Respiratory disease treatment
|
|
EA018061B1
|
|
Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
|
